Our study showed that individual compounds in this combination act as either tubulin polymerization inhibitors or histone deacetylase (HDAC) inhibitors.
The TMCG/DIPY combination acted as an epigenetic treatment that reactivated RASSF1A expression and induced E2F1-mediated apoptosis in breast cancer cells.
Immune complexes containing anti-dsDNA antibodies and immunostimulatory plasmid DNA in combination acted as potent inducers of IFN-α in natural interferon-producing cells [ 21].
Recently, we observed that the TMCG/DIPY combination acted as an epigenetic treatment that reactivated RASSF1A expression and induced apoptosis in breast cancer cells.
In this technique, a previously developed sampling probe is combined with a water-cooled circular plate such that the combination simultaneously acts as a flow stagnation surface and soot sample probe for mobility particle sizing.
The current chemotherapy for malaria as recommended by WHO focuses on artemisinin-based combination therapies (ACTs) as the front line of treatment for malaria disease.
Collectively, these observations have major public health consequences, as a shared drug defence mechanism will undermine the efficacy of Artemisinin Combination Therapies (ACTs) as a whole, and facilitate the evolution of resistance.
15 Over the past decade African countries have transitioned from CQ or SP to artemisinin-based combination therapies (ACTs) as a first-line policy for uncomplicated malaria.
